 |
Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndromes |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Opsona Therapeutics Limited |
| |
Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndromes |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Opsona Therapeutics Limited |